Related Experiment Video
Updated: Aug 16, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic value of a novel indicator integrating C-reactive protein-triglyceride glucose index and coronary
Xinjun Lin1,2,3,4,5, Yuanming Yan1,2,3,4,5, Hui Chen1,2,3,4,5
1Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Insights
A new integrated index, the C-reactive protein-triglyceride glucose index (CTI) combined with quantitative flow ratio (QFR), effectively predicts major adverse cardiovascular events after percutaneous coronary intervention (PCI). This combined index, called μCTI, offers improved risk stratification for patients with coronary artery disease.
Area of Science:
- Cardiology
- Biomarkers
- Interventional Cardiology
Background:
- Patients with coronary artery disease (CAD) often experience residual cardiovascular risk despite optimal therapy.
- Systemic inflammation (C-reactive protein-triglyceride glucose index, CTI) and coronary physiological burden (quantitative flow ratio, QFR) are key prognostic factors.
- The combined prognostic value of CTI and QFR after percutaneous coronary intervention (PCI) is not well understood.
Purpose of the Study:
- To evaluate the prognostic value of an integrated index combining CTI and residual coronary physiological burden in patients undergoing PCI.
- To assess the predictive capability of the novel μCTI index for major adverse cardiovascular and cerebrovascular events (MACCE).
Main Methods:
- A single-center registry study enrolled 1,468 patients with CAD undergoing PCI.
- A novel integrated index, μCTI, was derived from CTI and the sum of residual QFR in three major coronary vessels.
- The primary endpoint was MACCE (all-cause death, myocardial infarction, revascularization, or stroke) over a median 24-month follow-up.
Main Results:
- A total of 185 MACCE events (12.6%) were recorded.
- Each standard deviation increase in μCTI was independently associated with a 79% rise in MACCE risk (aHR=1.79, p<0.001).
- MACCE risk increased progressively across increasing μCTI quartiles, with a linear relationship observed between μCTI and MACCE risk.
Conclusions:
- The composite μCTI index serves as an independent predictive biomarker for patients post-PCI.
- μCTI provides supplementary risk stratification information, identifying individuals at elevated risk beyond single indicators.
- This combined index can be an auxiliary tool for risk assessment in patients undergoing PCI.
Background:
Patients with coronary artery disease (CAD) continue to face residual cardiovascular risk despite receiving guideline-directed optimal therapy. Both systemic metabolic-inflammatory dysregulation, reflected by the C-reactive protein-triglyceride glucose index (CTI), and coronary physiological burden, assessed by the quantitative flow ratio (QFR), are critical determinants of prognosis. However, the combined prognostic value of these two factors in patients after percutaneous coronary intervention (PCI) remains unclear. This study aimed to evaluate the prognostic value of an integrated index combining CTI with residual coronary physiological burden in patients undergoing PCI.
Methods:
This single-center registry study (ChiCTR2100042363) consecutively enrolled 1,468 patients with CAD who underwent PCI between March 2021 and February 2022. A novel integrated index, μCTI, was derived from the CTI and the sum of the residual QFR in the three major coronary vessels. The primary endpoint was major adverse cardiovascular and cerebrovascular events (MACCE), defined as a composite of all-cause death, non-fatal myocardial infarction (MI), ischemia-driven revascularization (IDR), or stroke.
Results:
During a median follow-up of 24 months, a total of 185 MACCE (12.6%) occurred. In multivariable Cox regression, each standard deviation increase in μCTI was independently associated with a 79% rise in MACCE risk [adjusted hazard ratio (HR) = 1.79, 95% CI: 1.54-2.07, p < 0.001]. Furthermore, MACCE risk progressively increased across ascending μCTI quartiles (P for trend < 0.001). Restricted cubic spline (RCS) analysis revealed a linear relationship between μCTI and MACCE risk (P for nonlinear = 0.058).
Conclusion:
The composite μCTI acts as an independent predictive biomarker and delivers supplementary risk stratification information for patients after PCI. This combined index could serve as an auxiliary tool to identify individuals at elevated risk of MACCE beyond single metabolic-inflammatory or coronary physiological indicators.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies